Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Nanosonics Limited ( (AU:NAN) ) just unveiled an announcement.
Nanosonics Limited has announced it will release its FY26 half-year financial results on 24 February 2026, accompanied by an investor briefing hosted by CEO & President Michael Kavanagh and CFO Jason Burriss. The company is offering both an audio webcast and a separate conference call for investors, with the latter providing an opportunity for questions, and will make a recording of the event available on its website, underlining its ongoing efforts to maintain active engagement and transparency with the investment community.
The most recent analyst rating on (AU:NAN) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is an Australian-based medical technology company specialising in infection prevention solutions. The company develops and supplies products aimed at reducing the risk of healthcare-associated infections, serving hospitals and healthcare providers in markets where high standards of disinfection and sterilisation are critical.
YTD Price Performance: 0.76%
Average Trading Volume: 373,171
Technical Sentiment Signal: Sell
Current Market Cap: A$1.21B
For detailed information about NAN stock, go to TipRanks’ Stock Analysis page.